HELP YOUR PATIENTS FIGHT BACK AGAINST
CHRONIC MIGRAINE

Download and view communication tips, documentation tools,
patient support materials, and information about treatment options

GET STARTED

Patient disease education campaign

Allergan continues its commitment to educating
patients about Chronic Migraine with brochures,
headache diaries, magazine ads, and more.



Visit the patient site

ABOUT CHRONIC MIGRAINE

Chronic Migraine is a prevalent and well-defined condition, yet many patients remain undiagnosed.1-7

ICHD-3 Beta* Criteria

Headache on ≥ 15 days per month for more
than 3 months

≥ 5 prior migraine attacks (with or without aura)

On ≥ 8 days per month for > 3 months,
headache fulfills criteria for migraine
headache (with or without aura)

Not better accounted for by another
ICHD-3 diagnosis

With or without medication overuse

PRACTICAL CLINICAL CRITERIA

Headache on ≥ 15 days per month

≥ 8 days are migraine days;
headaches last ≥ 4 hours per day

With or without medication overuse

3.2 million: Adults in the United States with Chronic Migraine

75%: Patients who do not receive a Chronic Migraine diagnosis despite meeting the criteria (n = 512)

56%: Patients who do not have their condition managed by a Headache Specialist (N = 609)

3.9: Number of preventive treatments the average Chronic Migraine patient has already tried (n = 493)

*The International Classification of Headache Disorders, 3rd edition (beta version).
Based on 2010 data estimating a 1.4% incidence of Chronic Migraine and a 234,504,070 US 2010 adult population (.014 x 234,504,070 ≈ 3.2 million).

DIAGNOSIS

Many patients struggle with debilitating headache for years without understanding the true nature of their condition.
A Chronic Migraine diagnosis can help patients better understand their condition and become more open to
treatment options.

Watch headache expert Dr. Lawrence Newman share strategies you can utilize to diagnose Chronic Migraine for your patients in need, including:

  • Focusing on headache days, rather than just migraine attacks, and asking about headache-free days

  • Considering days when a patient took an over-the-counter medication or simply dealt with the pain

  • Evaluating patients for medication-overuse headache

DOCUMENTATION

There are several factors to consider when diagnosing Chronic Migraine, including headache frequency, symptoms, duration, and day-to-day impact. Download these tools so patients can accurately document their headache burden to help a doctor with a Chronic Migraine diagnosis.

PATIENT EDUCATION

As patients learn more about their condition, they may begin to feel less frustrated and become willing to discuss different treatment options. Provide these resources to your patients to help educate them about Chronic Migraine and available treatments.

TREATMENT OPTIONS

A complete Chronic Migraine management plan may include both acute
and preventive treatments.8

Acute treatment*

Acute medications are an important treatment option for Chronic
Migraine patients and should be optimized to help avoid medication
overuse. Withdrawal from acute medications and preventive treatment
may be appropriate in cases of medication overuse.8,9

Preventive treatment*

According to expert opinion, people with Chronic Migraine could
benefit from a preventive treatment ,10 and many patients have tried
several already.

Learn more about a preventive treatment option

*Help your patients understand their treatment options. Acute treatments are taken as needed when a
  migraine/headache is starting or has already begun, and may stop or reduce pain. Preventive (prophylactic)
  treatments are taken on a schedule and may prevent migraine/headache days before they start.

References: 1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808. 2. Lipton RB. Chronic migraine, classification, differential diagnosis, and epidemiology. Headache. 2011;51(suppl 2):77S-83S. 3. Natoli JL, Manack A, Dean B, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010;30(5):599ยท609. 4. Centers for Disease Control and Prevention. Census projections request. CDC WONDER website. http://wonder.cdc.gov/population-projections.html. Accessed March 20, 2017. 5. Dodick DW, Loder EW, Manack A. Assessing barriers to Chronic Migraine consultation, diagnosis, and treatment: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study. [published online ahead of print May 3, 2016]. Headache. doi: 10.1111/head.12774. 6. Data on file, Allergan; Millward Brown Chronic Migraine Analysis. 7. Blumenfeld AM, Bloudek LM, Becker WJ, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the Second International Burden of Migraine Study (IBMS-II). Headache. 2013;53(4):644-655. 8. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754-762. 9. Kristoffersen ES, Lundqvist C. Medication-overuse headache: a review. J Pain Res. 2014;26(7):367-378. 10. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71(8):559-566.

Privacy Policy